Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Can the advertisements in a reputable medical journal promote quackery?.
J Am Med Assoc, 22 (1894), pp. 958
[2.]
J.P. Kassirer.
Pharmaceutical advertising in the journal.
N Engl J Med, 327 (1992), pp. 1689
[3.]
D. Rennie.
Editors and advertisements. What responsibility do editors have for the advertisements in their journals?.
J Am Med Assoc, 265 (1991), pp. 2394-2396
[4.]
R.H. Fletcher, S.W. Fletcher.
Pharmaceutical advertisements in medical journals.
Ann Intern Med, 116 (1992), pp. 951-952
[5.]
J. Rutter, R. Smith.
Publishing research supported by the tobacco industry. Journals should reverse ban on industry sponsored research.
Br Med J, 312 (1996), pp. 133-134
[6.]
B. Gitanjali, C.H. Shashindran, K.D. Tripathi, K.R. Sethuraman.
Are drug advertisements in Indian edition of BMJ unethical?.
Br Med J, 315 (1997), pp. 459
[7.]
A. Herxheimer, C.S. Lundborg, B. Westerholm.
Advertisements for medicines in leading medical journals in 18 countries: a 12- month survey of information content and standards.
Int J Health Serv, 23 (1993), pp. 161-172
[8.]
K.J. Tietze, M.C. Smith.
More on sex and racial bias in pharmaceutical advertisements.
N Engl J Med, 322 (1990), pp. 1534
[9.]
P.A. Glassman, J. Hunter-Hayes, T. Nakamura.
Pharmaceutical advertising revenue and physician organization: how much is too much?.
West Med J, 171 (1999), pp. 234-238
[10.]
International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Updated May 2000. Disponible en: www.icmje.org Acceso en enero, 2001
[11.]
Retractación de "colaboraciones especiales".
Rev Calidad Asistencial, 16 (2001), pp. 149
Copyright © 2001. Sociedad Española de Calidad Asistencial
